Page results
-
This page is for parents, carers and family members who are acting as comforters and carers for children and young people having radioactive iodine (131I) treatment. It explains what the treatment involves, how to prepare for it and what you can expect afterwards.
-
We are now administering new COVID-19 treatments for patients at highest risk in the community. The service can prescribe oral antivirals to be taken at home, and give intravenous antibody treatments at the hospital.
-
An ILR is a sealed metal and plastic device, which contains a battery and electronic circuits. ILR is offered to patients who have symptoms / possible symptoms that could be result of an arrhythmia.
-
Leila Hail and Gema Martinez-Garcia have been announced as finalists for the 2021 Royal College of Nursing (RCN) Awards in the Outstanding Contribution to Infection Prevention and Control category.
-
Dr Stephen Daw is a consultant paediatric and adolescent haemato-oncologist who specialises in treating children and young people with haematological malignancies. He has a particular interest in Hodgkin lymphoma and non-Hodgkin's lymphoma.
-
Dr Saifee is a consultant neurologist with expertise in movement disorders. He has a particular interest in tremor, dystonia and Parkinson’s disease.
-
Professor Warner specialises in movement disorders and has particular expertise in Parkinson’s disease and allied conditions, dystonia, chorea, familial spasticity, Wilson’s disease and tremor.
-
Dr Yen Ching Chang has been a consultant radiotherapist at UCLH since 2005. She has a specialist practice in paediatric radiotherapy (in particular neuro oncology and haematological malignancies) as well as in the late effects of childhood cancers and their treatment. Her research interests are Proton beam therapy, paediatric brian tumours, Hodgkins' lymphoma and late effects following childhood cancer.
-
The COVID Medicines Delivery Unit (CMDU gives new COVID-19 treatments for patients at highest risk in the community from the NCL sector. These treatments involve intravenous infustion of neutralising monoclonal antibodies (nMABs) or oral antiviral treatments, which are given to high-risk patients who have had a positive PCR test.
-
Information and contact details for our arts and heritage team and UCLH archivist